SCHEMBL4773807

SCHEMBL4773807

CCCCC(=O)OCSC(=S)c1cc(N2CCCC2)c(Oc2ccccc2)c(S(N)(=O)=O)c1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.60
LMNA P02545 3/20 0.60
KDM4E B2RXH2 2/20 0.60
USP2 O75604 2/20 0.60
HPGD P15428 2/20 0.60
HIF1A Q16665 2/20 0.60
HSD17B10 Q99714 2/20 0.60
SLC6A4 P31645 1/20 0.60
CA2 P00918 1/20 0.44
TSHR P16473 1/20 0.44
BLM P54132 1/20 0.44
SLC12A2 P55011 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
PTGS2 P35354 15/20 0.42
AQP1 P29972 1/20 0.39
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29436054 0.87 ALDH1A1 (0.64) ALDH1A1LMNAKDM4EUSP2HPGD
SCHEMBL230346 0.87 ALDH1A1 (0.64) ALDH1A1LMNAKDM4EUSP2HPGD
SCHEMBL1739516 0.82 KDM4E (0.68) ALDH1A1LMNAKDM4EUSP2HPGD
SCHEMBL230174 0.81 LMNA (0.73) ALDH1A1LMNAKDM4EUSP2HPGD
SCHEMBL29436032 0.80 KDM4E (0.61) ALDH1A1LMNAKDM4EUSP2HPGD
SCHEMBL30754392 0.78 ALDH1A1 (0.75) ALDH1A1LMNAKDM4EUSP2HPGD
SCHEMBL18993642 0.78 ALDH1A1 (0.78) ALDH1A1LMNAKDM4EUSP2HPGD
SCHEMBL229366 0.78 ALDH1A1 (0.81) ALDH1A1LMNAKDM4EUSP2HPGD
SCHEMBL29436034 0.77 ALDH1A1 (0.70) ALDH1A1LMNAKDM4EUSP2HPGD
SCHEMBL232305 0.77 ALDH1A1 (0.70) ALDH1A1LMNAKDM4EUSP2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1951702-A2 DIURETIC-LIKE COMPOUND ANALOGS USEFUL FOR REGULATION OF CENTRAL NERVOUS SYSTEM DISORDERS NeuroTherapeutics Pharma, Inc. (US) 2008-08-06 EP disclosed
EP-1937242-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROPSYCHIATRIC AND ADDICTIVE DISORDERS NeuroTherapeutics Pharma, Inc. (US) 2008-07-02 EP disclosed
WO-2007047447-A2 DIURETIC-LIKE COMPOUND ANALOGS USEFUL FOR REGULATION OF CENTRAL NERVOUS SYSTEM DISORDERS NEUROTHERAPEUTICS PHARMA, INC. (US) 2007-04-26 WO disclosed
WO-2007047698-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROPSYCHIATRIC AND ADDICTIVE DISORDERS NEUROTHERAPEUTICS PHARMA, INC. (US) 2007-04-26 WO disclosed